The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUAI.L Regulatory News (UAI)

  • There is currently no data for UAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Development & Trading Update

20 Mar 2020 07:00

RNS Number : 8923G
U and I Group PLC
20 March 2020
 

 

This announcement contains inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

 

20 March 2020

 

U and I Group PLC

 

Development & Trading Update

U+I (LSE:UAI), the specialist regeneration developer and investor, today announces an update to its anticipated development and trading gains for FY2020.

Brexit, the related slowdown in decision-making and the only recently resolved political uncertainty in the UK have continued to impact upon timing of some of our projects. In particular this has led to delays in securing planning consents following the election purdah and a further slowdown in transaction timetables. This has recently been dramatically exacerbated by the impact of Covid-19 on the decision-making process, business sentiment and economic activity. The rapidly accelerating impact of the Covid-19 crisis on transactional activity and Central and Local Government policy means that there is currently no reliable way to predict, with certainty, the timing or value of transactions. However, it is now unlikely that sufficient of the projects set out in our guidance at our interim results on 20 November 2019 will contract by 31 March 2020 to enable us to meet the lower end - £35 million - of our gains target for the year. In the normal course of events, we would expect some of the deferred projects to be realised in FY2021 and will provide further detail of these in our full year results.

Based on the projects on which we have certainty, the aggregate amount of our development and trading gains number is currently materially below that £35 million target for the full year. That said, we remain in advanced legal negotiations on several projects within our flexible and substantial development portfolio, including Harwell. If successfully concluded, these could have a material impact on our reported end of year total gains, albeit we expect that amount would still be below the £35 million lower end target. Given the confidential nature of these discussions, the Company is not yet in a position to provide a more detailed review of target gains as it believes this could prejudice its commercial position.

U+I has been actively managing its cost base and in the current climate it will be proactively reducing its operating expenses and all non-essential capital expenditure, with regular discussions to review these key areas and help mitigate risk. It also has the ability to access credit facilities should they be required to manage its liquidity needs, utilising its currently uncharged assets as security.

In addition to RNS releases once transactions close, a post close statement will be issued in early April updating the market on gains, trading and its cost mitigation actions.

Ends

 

 

 

For further information, please contact: 

 

U+I

Nicola Krafft

+44 (0) 20 7828 4777

ir@uandiplc.com

 

Camarco (Financial PR Adviser)

Geoffrey Pelham-Lane / Tom Huddart

+44 (0)20 3757 4985 / 4991

uandi@camarco.co.uk 

 

About U+I

U+I is a specialist regeneration developer and investor.

 

With a >£11.5 billion portfolio of complex, mixed-use, community-focused regeneration projects including a £147.1 million investment portfolio, we are unlocking urban sites bristling with potential in the London City Region (within one hour's commute from Central London), Manchester and Dublin. We exist to create long-term socio-economic benefit for the communities in which we work, delivering sustainable returns to our shareholders.

 

To find out more, visit www.uandiplc.com or follow us @uandiplc  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUKRRRRSUOAUR
Date   Source Headline
10th Sep 20207:00 amRNSAGM Trading Update
6th Aug 20202:59 pmRNSDirector/PDMR Shareholding
4th Aug 202011:25 amRNSMayfield secures £23m in Government funding
31st Jul 20207:00 amRNSAnnual Financial Report
31st Jul 20207:00 amRNSExtension in the maturity of unsecured loan notes
8th Jul 20207:00 amRNSResults for the year ended 31 March 2020
1st Jul 202010:56 amRNSDirector/PDMR Shareholding
1st Jul 20207:00 amRNSBlock listing Interim Review
26th Jun 20207:00 amRNSPositive planning decision at Kensington Ch. St.
22nd Jun 20207:00 amRNSPlanning application submitted for £770m scheme
16th Jun 20207:00 amRNSPositive planning decision at Landmark Court
12th Jun 20207:00 amRNS8 Albert Embankment update
11th Jun 20207:00 amRNSNotice of Preliminary Results
9th Jun 20205:04 pmRNSHolding(s) in Company
5th Jun 202010:53 amRNSHolding(s) in Company
3rd Jun 20204:41 pmRNSSecond Price Monitoring Extn
3rd Jun 20204:37 pmRNSPrice Monitoring Extension
12th May 20206:19 pmRNSHolding(s) in Company
23rd Apr 20207:00 amRNSResolution to grant planning and acquisition
15th Apr 20207:00 amRNSPost Close Trading Update
2nd Apr 20207:00 amRNSDisposal of Share in Harwell Campus
1st Apr 20202:49 pmRNSDirector/PDMR Shareholding
30th Mar 20204:50 pmRNSHolding(s) in Company
27th Mar 20207:00 amRNSDisposal of three non-core assets
20th Mar 20207:00 amRNSDevelopment & Trading Update
13th Feb 20204:01 pmRNSPositive planning decision for Phase 1 at Mayfield
24th Jan 20203:16 pmRNSDirector/PDMR Shareholding
6th Jan 20203:06 pmRNSDirector/PDMR Shareholding
20th Dec 20197:00 amRNSPlans submitted at Faraday Works, Greenwich
17th Dec 20192:43 pmRNSBlock listing Interim Review
13th Dec 20191:15 pmRNSDirector/PDMR Shareholding
10th Dec 20194:39 pmRNSHolding(s) in Company
4th Dec 20197:00 amRNSPositive planning decision at 8 Albert Embankment
3rd Dec 20192:16 pmRNSDirector/PDMR Shareholding
3rd Dec 201911:02 amRNSDirector/PDMR Shareholding
28th Nov 201911:58 amRNSDirector/PDMR Shareholding
28th Nov 201911:14 amRNSDirector/PDMR Shareholding
28th Nov 201911:12 amRNSDirector/PDMR Shareholding
27th Nov 20199:07 amRNSDirector/PDMR Shareholding
22nd Nov 20198:40 amRNSDirector/PDMR Shareholding
20th Nov 20197:00 amRNSInterim Results
23rd Oct 201912:17 pmRNSHolding(s) in Company
23rd Oct 201912:02 pmRNSHolding(s) in Company
2nd Oct 20197:00 amRNSCapital Markets Day
5th Sep 20197:00 amRNSPlanning permission at Swanley Shopping Centre
4th Sep 20194:37 pmRNSResult of AGM
27th Aug 20192:00 pmRNSClarification following press article
5th Aug 20193:23 pmRNSHolding(s) in Company
2nd Aug 20193:01 pmRNSHolding(s) in Company
8th Jul 20193:02 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.